Article Information
History
- September 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Riya Mukherjee1,
- Ramendra Pati Pandey2,+,
- Gunjan1,
- Himanshu1,
- Ing-Kae Wang3,
- Sing-Ying Hsieh3 and
- Chung-Ming Chang1,4,5,*
- 1Graduate Institute of Biomedical Sciences, Chang Gung University
- 2School of Health Sciences and Technology (SoHST), UPES Dehradun, Uttarakhand, India
- 3Cell Culture Medium Technology Development, Regeneration Medicine Technology Division, Biomedical Technology and Device Research Laboratories, ITRI, Chutung, Hsinchu, Taiwan 310401, R.O.C
- 4Master & Ph.D Program in Biotechnology Industry, Chang Gung University
- 5Department of Medical Biotechnology and Laboratory Science; Chang Gung University
- ↵*Corresponding author
Chung-Ming Chang, Master & Ph.D. program in Biotechnology Industry, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist. Taoyuan City 33302, Taiwan (R.O.C.), cmchang{at}mail.cgu.edu.tw (C.M.C.).
↵+ Contributed equally as first authorship
Posted September 22, 2024.
Comprehensive Analysis of Therapeutic Strategies Using Mesenchymal Stem Cell-Derived Exosomes in Preclinical Models of Osteoarthritis
